Yan Zhan
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Engineering Properties of GeSi Alloy Quantum Dots by High-Temperature Annealing.
Journal: Nanomaterials (Basel, Switzerland)
Published: May 12, 2026
Development and validation of an LC-MS/MS method with precolumn derivatization for the determination of dimethoxyethyl phthalate metabolites ethylene glycol methyl ether and methoxyacetic acid in rat plasma.
Journal: Journal of pharmaceutical and biomedical analysis
Published: October 24, 2024
Competitive Growth of Ge Quantum Dots on a Si Micropillar with Pits for a Precisely Site-Controlled QDs/Microdisk System.
Journal: Nanomaterials (Basel, Switzerland)
Published: July 01, 2023
Effects of health education during public health emergencies on the health literacy, emotion and coping style of Chinese junior middle school students: a randomized controlled trial.
Journal: BMC public health
Published: June 15, 2023
Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluoroazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain.
Journal: European journal of medicinal chemistry
Published: March 08, 2023
Mass balance study of [14C]SHR0302, a selective and potent JAK1 inhibitor in humans.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: February 06, 2023
A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans.
Journal: Frontiers in pharmacology
Published: December 05, 2022
Simultaneous quantification of 3',4'-dimethoxy flavonol-3-O-glucoside and its major metabolite in human plasma by LC-MS/MS and its application to a clinical pharmacokinetic study.
Journal: Journal of pharmaceutical and biomedical analysis
Published: October 05, 2022
Absorption, metabolism, and excretion of [14C]YY-20394, a highly selective PI3K-Delta inhibitor in humans.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: April 04, 2022
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor.
Journal: Journal of separation science
Published: June 21, 2021
Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: June 14, 2021
Last Updated: 09/26/2026